Alan R. Katz to Colorectal Neoplasms
This is a "connection" page, showing publications Alan R. Katz has written about Colorectal Neoplasms.
Connection Strength
0.446
-
Bates JE, Choi G, Usuki KY, Katz AW, Milano MT. Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy. Am J Clin Oncol. 2018 12; 41(12):1172-1175.
Score: 0.117
-
Qiu H, Katz AW, Chowdhry AK, Usuki KY, Singh DP, Metcalfe S, Cheruvu P, Chen Y, Okunieff P, Milano MT. Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival. Am J Clin Oncol. 2018 Jan; 41(1):53-58.
Score: 0.110
-
Bapuji SB, Lobchuk MM, McClement SE, Sisler JJ, Katz A, Martens P. Fecal occult blood testing instructions and impact on patient adherence. Cancer Epidemiol. 2012 Aug; 36(4):e258-64.
Score: 0.074
-
Lobchuk MM, Bapuji SB, McClement SE, Sisler JJ, Katz A, Martens P, Turner D, Clouston K. What is the role of family in promoting faecal occult blood test screening? Exploring physician, average-risk individual, and family perceptions. Cancer Epidemiol. 2012 Jun; 36(3):e190-9.
Score: 0.073
-
Sisler JJ, Seo B, Katz A, Shu E, Chateau D, Czaykowski P, Wirtzfeld D, Singh H, Turner D, Martens P. Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis. J Oncol Pract. 2012 Jul; 8(4):e69-79.
Score: 0.073